[go: up one dir, main page]

ES250491A1 - New substituted 3,5-dioxo-isoxazolidines and process for the manufacture thereof - Google Patents

New substituted 3,5-dioxo-isoxazolidines and process for the manufacture thereof

Info

Publication number
ES250491A1
ES250491A1 ES0250491A ES250491A ES250491A1 ES 250491 A1 ES250491 A1 ES 250491A1 ES 0250491 A ES0250491 A ES 0250491A ES 250491 A ES250491 A ES 250491A ES 250491 A1 ES250491 A1 ES 250491A1
Authority
ES
Spain
Prior art keywords
malonylating
hydrogen atom
prepared
hydrocarbon radical
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0250491A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haco AG
Original Assignee
Haco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haco AG filed Critical Haco AG
Publication of ES250491A1 publication Critical patent/ES250491A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention comprises compounds having, in one tautomeric form, the general formula <FORM:0914716/IV (b)/1> (wherein R, R1 and R2 each represent a hydrogen atom or a hydrocarbon radical free from aliphatic unsaturated bonds, at least one but not more than two of them representing a hydrogen atom), and their salts with inorganic or organic bases (e.g. alkali and alkalineearth metals, ammonium, methylamine, monoand di-ethanolamine, triethylamine, diethylaminoethanol and morpholine), and the preparation thereof by condensing a compound RNH.OH with a malonylating agent capable of supplying a malonyl group of the formula <FORM:0914716/IV (b)/2> and, if desired, when a product is obtained in which R1 = R2 = H, substituting it with a hydrocarbon radical free from aliphatic unsubstitution, and further, if desired, reacting the product with a base to form a salt. Substituted malonyl chlorides for use as malonylating agents are prepared by treating the corresponding acid with thionyl chloride. n-Nonylmalonic acid is prepared by saponifying its diethyl ester with aqueous ethanolic caustic potash, distilling off the ethanol and acidifying the residual aqueous solution. Pharmaceutical compositions.-The products are useful for the treatment of inflammatory phenomena, for which purpose they may be administered orally (e.g. in tablets, sugarcoated pills or capsules) or parenterally (e.g. dissolved in water, propylene glycol or polyethylene glycol).
ES0250491A 1958-07-03 1959-07-02 New substituted 3,5-dioxo-isoxazolidines and process for the manufacture thereof Expired ES250491A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH6134458A CH368175A (en) 1958-07-03 1958-07-03 Process for the preparation of 3,5-dioxo-isoxazolidines

Publications (1)

Publication Number Publication Date
ES250491A1 true ES250491A1 (en) 1960-01-16

Family

ID=4523565

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0250491A Expired ES250491A1 (en) 1958-07-03 1959-07-02 New substituted 3,5-dioxo-isoxazolidines and process for the manufacture thereof

Country Status (4)

Country Link
BE (1) BE580263A (en)
CH (1) CH368175A (en)
ES (1) ES250491A1 (en)
GB (1) GB914716A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946963A (en) * 1987-11-13 1990-08-07 The University Of North Carolina At Chapel Hill Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones

Also Published As

Publication number Publication date
CH368175A (en) 1963-03-31
BE580263A (en) 1959-11-03
GB914716A (en) 1963-01-02

Similar Documents

Publication Publication Date Title
US2642451A (en) Thiolurethanes and processes for
ES250753A1 (en) Process for the preparation of o,o-dialkyl-dithiophosphoryl-fatty acid compounds and pesticidal compositions containing the same
GB854087A (en) Improvements in coating out aqueous gelatin compositions including gelatin-silver halide emulsions
GB1077076A (en) Novel imidazole derivatives and a process for the manufacture thereof
ES250491A1 (en) New substituted 3,5-dioxo-isoxazolidines and process for the manufacture thereof
GB871757A (en) Basically substituted diphenyl-carbinol-esters and a process for their manufacture
DE69414586T2 (en) METHOD FOR PRODUCING INDOLICINE DERIVATIVES
GB835737A (en) Salts of ª‡-hydroxy-1:2:5:6-tetrahydrobenzylphosphonous acid and a process for their manufacture
US3213140A (en) 2-phenyl-4, 6-dichlorophenoxyethylamine and salts thereof
US3649678A (en) Substituted cycloalkane-alkanoic acids
US3705920A (en) Sulfonylphenylphosphonic acids
US3412091A (en) 1, 1-diphenyl-2-methyl-3-(3, 5-dimethylmorpholino)propanols
US2558146A (en) 2-isopropylmethylaminoethyl ester of phenylcyclopentylacetic acid and salts thereof
US2674615A (en) 1-arylcycloalkane 1-thiocar-boxylates
GB1315542A (en) 4-phenyl-butyric acid derivatives
DE2034143C3 (en) Isobutylcyclohexene compounds, their physiologically tolerable salts and medicaments containing them
GB922187A (en) Phenothiazines and their preparation
US3629442A (en) Sulphonamides for treating hypertension
GB847779A (en) 2-(4-biphenylyl)-í¸-hexenoic acid esters thereof
GB922269A (en) Improvements in or relating to derivatives of 1, 2, 3, 6-tetrahydro-2, 6-dioxo-4-pyrimidine-carboxylic acid
GB1088224A (en) Acetamidine derivatives
US3366660A (en) Dibenzo cycloheptene thioiminoesters
GB1088346A (en) ª‡-aminocarboxylic acid esters and a process for their manufacture
ES278797A1 (en) New uracil derivatives and process for their production
Ratchford Lactic Acid Derivatives. 4, 4, 6-Trimethyl-2-(1-hydroxyethyl)-5, 6-dihydro-1, 3, 4H-oxazine1